Pnc Financial Services Group, Inc. Adaptive Biotechnologies Corp Transaction History

Pnc Financial Services Group, Inc.

$148 Billion
Q4 2024

A detailed history of Pnc Financial Services Group, Inc. transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 1,367 shares of ADPT stock, worth $11,305. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,367

Previous 2,992 54.31%

Holding current value

$11,305

Previous $15,000 46.67%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 07, 2025	SELL	$4.37 - $6.78 $7,101 - $11,017	-1,625 Reduced 54.31%	1,367 $8,000
Q3 2024 Nov 08, 2024	SELL	$3.37 - $5.12 $14,828 - $22,528	-4,400 Reduced 59.52%	2,992 $15,000
Q2 2024 Aug 09, 2024	SELL	$2.34 - $3.96 $4,766 - $8,066	-2,037 Reduced 21.6%	7,392 $26,000
Q1 2024 May 10, 2024	BUY	$2.88 - $4.8 $4,651 - $7,752	1,615 Added 20.67%	9,429 $30,000
Q4 2023 Feb 09, 2024	SELL	$3.46 - $5.33 $1,134 - $1,748	-328 Reduced 4.03%	7,814 $38,000
Q3 2023 Nov 13, 2023	SELL	$5.07 - $8.44 $1,470 - $2,447	-290 Reduced 3.44%	8,142 $44,000
Q2 2023 Aug 11, 2023	BUY	$6.19 - $8.78 $9,823 - $13,933	1,587 Added 23.18%	8,432 $56,000
Q1 2023 May 15, 2023	SELL	$7.8 - $10.11 $319 - $414	-41 Reduced 0.6%	6,845 $60,000
Q4 2022 Feb 10, 2023	SELL	$6.26 - $9.34 $12,457 - $18,586	-1,990 Reduced 22.42%	6,886 $52,000
Q3 2022 Nov 10, 2022	BUY	$6.5 - $12.67 $32,350 - $63,058	4,977 Added 127.65%	8,876 $63,000
Q2 2022 Aug 12, 2022	SELL	$6.4 - $14.73 $8,921 - $20,533	-1,394 Reduced 26.34%	3,899 $31,000
Q1 2022 May 12, 2022	BUY	$10.12 - $28.9 $34,205 - $97,682	3,380 Added 176.69%	5,293 $73,000
Q4 2021 Feb 11, 2022	SELL	$25.17 - $36.85 $83,891 - $122,821	-3,333 Reduced 63.53%	1,913 $53,000
Q3 2021 Nov 05, 2021	SELL	$30.02 - $39.87 $74,209 - $98,558	-2,472 Reduced 32.03%	5,246 $178,000
Q2 2021 Aug 06, 2021	SELL	$32.22 - $44.59 $65,793 - $91,052	-2,042 Reduced 20.92%	7,718 $315,000
Q1 2021 May 07, 2021	SELL	$37.26 - $67.74 $6,110 - $11,109	-164 Reduced 1.65%	9,760 $392,000
Q4 2020 Feb 12, 2021	BUY	$45.01 - $65.47 $160,325 - $233,204	3,562 Added 55.99%	9,924 $586,000
Q3 2020 Nov 06, 2020	SELL	$35.79 - $48.81 $9,770 - $13,325	-273 Reduced 4.11%	6,362 $309,000
Q2 2020 Aug 07, 2020	BUY	$24.95 - $48.38 $149,350 - $289,602	5,986 Added 922.34%	6,635 $321,000
Q1 2020 May 08, 2020	BUY	$16.96 - $34.16 $186 - $375	11 Added 1.72%	649 $18,000
Q4 2019 Feb 07, 2020	SELL	$24.56 - $32.8 $73 - $98	-3 Reduced 0.47%	638 $19,000
Q3 2019 Nov 08, 2019	BUY	$30.31 - $53.51 $19,428 - $34,299	641 New	641 $19,000

Others Institutions Holding ADPT

# of Institutions

225

Shares Held

146M

Call Options Held

19.6K

Put Options Held

27.2K

View Full List

About Adaptive Biotechnologies Corp

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $1.18B
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

More about ADPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.

Account

Pnc Financial Services Group, Inc. Adaptive Biotechnologies Corp Transaction History